Engineering proteins to support novel metabolic pathways is a very laborious process, requiring many costly Design-Build-Test cycles. We developed a technology to optimize novel proteins and pathways in a fast and cheap manner.
We engineer bacteria as biosensors for the activity of novel and promising pathways: no pathway activity – no growth; low pathway activity – low growth; high pathway activity – high growth.
We grow the bacteria for many generations in only a few weeks – much faster than any plant could grow. During these short bacterial life cycles very fast evolution takes place: changes to pathway proteins emerge spontaneously and the best pathway variant arises naturally as it outgrows the lesser variants and takes over the bacterial population.
Addressing target audiences and expressing needs
- Legal / IPR advise
- Investor introductions
- Business plan development
- Expanding to more markets /finding new customers
- Other Actors who can help us fulfil our market potential
- Private Investors
Result submitted to Horizon Results Platform by MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
